drugset / Trial / NCT01155986

Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain

NCT01155986

Phase 2 Terminated 74 enrolled Grünenthal GmbH
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this trial is to investigate the efficacy and safety of lidocaine 5% medicated plaster in localized chronic post-operative neuropathic pain in comparison to placebo plaster.

Timeline

Start
2010-08
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 700 mg Topical